Association between IL-6 production in synovial explants from rheumatoid arthritis patients and clinical and imaging response to biologic treatment: A pilot study.

about

Association between IL-6 production in synovial explants from rheumatoid arthritis patients and clinical and imaging response to biologic treatment: A pilot study.

Item

http://www.wikidata.org/entity/Q54917641

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Association between IL-6 produ ...... ogic treatment: A pilot study.

@en

Association between IL-6 produ ...... ogic treatment: A pilot study.

@nl

type

Item

label

Association between IL-6 produ ...... ogic treatment: A pilot study.

@en

Association between IL-6 produ ...... ogic treatment: A pilot study.

@nl

prefLabel

Association between IL-6 produ ...... ogic treatment: A pilot study.

@en

Association between IL-6 produ ...... ogic treatment: A pilot study.

@nl

P1476

Association between IL-6 produ ...... ogic treatment: A pilot study.

@en

P2093

Bente Danneskiold-Samsøe

http://www.w3.org/2001/XMLSchema#string

Kalle Söderström

http://www.w3.org/2001/XMLSchema#string

Karen Ellegaard

http://www.w3.org/2001/XMLSchema#string

Lars Karlsson

http://www.w3.org/2001/XMLSchema#string

Mikael Boesen

http://www.w3.org/2001/XMLSchema#string

Niels H Søe

http://www.w3.org/2001/XMLSchema#string

Pieter Spee

http://www.w3.org/2001/XMLSchema#string

Søren Torp-Pedersen

http://www.w3.org/2001/XMLSchema#string

Ulrik G W Mørch

http://www.w3.org/2001/XMLSchema#string

P2860

The pathogenesis of rheumatoid arthritis

Synovial explant inflammatory mediator production corresponds to rheumatoid arthritis imaging hallmarks: a cross-sectional study.

The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis.

Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study.

The Disease Activity Score and the EULAR response criteria.

Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial.

Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model

Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists

Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures

A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm.

P304

e0197001

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0197001

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

H Bliddal

Else Marie Bartels

Martin Andersen

P577

2018-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29787569

http://www.w3.org/2001/XMLSchema#string

P932

5963776

http://www.w3.org/2001/XMLSchema#string